Cargando…

Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial

INTRODUCTION: Phosphodiesterase 5 inhibitors are the predominant treatment option for erectile dysfunction. AIM: This study evaluates the efficacy and safety of sildenafil orally disintegrating strips for the treatment of erectile dysfunction. METHODS: One hundred twenty erectile dysfunction patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Sangkum, Premsant, Sirisopana, Kun, Matang, Wijittra, Phengsalae, Yada, Lertsithichai, Panuwat, Ketsuwan, Chinnakhet, Kochakarn, Wachira, Kongchareonsombat, Wisoot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766267/
https://www.ncbi.nlm.nih.gov/pubmed/34710784
http://dx.doi.org/10.1016/j.esxm.2021.100453
_version_ 1784634491550040064
author Sangkum, Premsant
Sirisopana, Kun
Matang, Wijittra
Phengsalae, Yada
Lertsithichai, Panuwat
Ketsuwan, Chinnakhet
Kochakarn, Wachira
Kongchareonsombat, Wisoot
author_facet Sangkum, Premsant
Sirisopana, Kun
Matang, Wijittra
Phengsalae, Yada
Lertsithichai, Panuwat
Ketsuwan, Chinnakhet
Kochakarn, Wachira
Kongchareonsombat, Wisoot
author_sort Sangkum, Premsant
collection PubMed
description INTRODUCTION: Phosphodiesterase 5 inhibitors are the predominant treatment option for erectile dysfunction. AIM: This study evaluates the efficacy and safety of sildenafil orally disintegrating strips for the treatment of erectile dysfunction. METHODS: One hundred twenty erectile dysfunction patients were enrolled in a prospective, randomized, controlled crossover study and allocated into 2 groups of 60 participants. Patients were either treated with sildenafil strips or tablets for 8 weeks after which they crossed over into the alternate treatment formulation for another 8 weeks following a 4-week wash-out period. Each participant was assessed 8 times throughout the study period and their formulation preference registered at the end of the study. MAIN OUTCOMES AND MEASURES: Changes in the abridged International Index of Erectile Function (IIEF-5) score and Erection Hardness Score (EHS) resulting from sildenafil orally disintegrating strip or tablet treatments were the primary end points, with differences in onset of action, duration of action, and incidence of adverse events between the 2 formulations included as secondary end points. RESULTS: Both sildenafil formulations were effective in treating patients with erectile dysfunction. There was significant improvement of erectile function in term of IIEF-5 score and EHS from both formulations. The number and type of adverse events were also comparable. Likewise, there were no statistically significant differences between the earliest onset of action times and longest duration of action times. However, the results showed a 7.1-minute earlier onset of action time for orally disintegrating strips that may be considered as clinically meaningful by some patients. CONCLUSION: Sildenafil orally disintegrating strips are a safe and effective alternative to the conventional tablet formulation for the treatment of erectile dysfunction. Sangkum P, Sirisopana K, Matang W, et al. Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial. Sex Med 2021;9:100453.
format Online
Article
Text
id pubmed-8766267
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87662672022-01-21 Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial Sangkum, Premsant Sirisopana, Kun Matang, Wijittra Phengsalae, Yada Lertsithichai, Panuwat Ketsuwan, Chinnakhet Kochakarn, Wachira Kongchareonsombat, Wisoot Sex Med Original Research INTRODUCTION: Phosphodiesterase 5 inhibitors are the predominant treatment option for erectile dysfunction. AIM: This study evaluates the efficacy and safety of sildenafil orally disintegrating strips for the treatment of erectile dysfunction. METHODS: One hundred twenty erectile dysfunction patients were enrolled in a prospective, randomized, controlled crossover study and allocated into 2 groups of 60 participants. Patients were either treated with sildenafil strips or tablets for 8 weeks after which they crossed over into the alternate treatment formulation for another 8 weeks following a 4-week wash-out period. Each participant was assessed 8 times throughout the study period and their formulation preference registered at the end of the study. MAIN OUTCOMES AND MEASURES: Changes in the abridged International Index of Erectile Function (IIEF-5) score and Erection Hardness Score (EHS) resulting from sildenafil orally disintegrating strip or tablet treatments were the primary end points, with differences in onset of action, duration of action, and incidence of adverse events between the 2 formulations included as secondary end points. RESULTS: Both sildenafil formulations were effective in treating patients with erectile dysfunction. There was significant improvement of erectile function in term of IIEF-5 score and EHS from both formulations. The number and type of adverse events were also comparable. Likewise, there were no statistically significant differences between the earliest onset of action times and longest duration of action times. However, the results showed a 7.1-minute earlier onset of action time for orally disintegrating strips that may be considered as clinically meaningful by some patients. CONCLUSION: Sildenafil orally disintegrating strips are a safe and effective alternative to the conventional tablet formulation for the treatment of erectile dysfunction. Sangkum P, Sirisopana K, Matang W, et al. Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial. Sex Med 2021;9:100453. Elsevier 2021-10-26 /pmc/articles/PMC8766267/ /pubmed/34710784 http://dx.doi.org/10.1016/j.esxm.2021.100453 Text en Copyright © 2021 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Sangkum, Premsant
Sirisopana, Kun
Matang, Wijittra
Phengsalae, Yada
Lertsithichai, Panuwat
Ketsuwan, Chinnakhet
Kochakarn, Wachira
Kongchareonsombat, Wisoot
Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial
title Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial
title_full Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial
title_fullStr Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial
title_full_unstemmed Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial
title_short Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial
title_sort efficacy of the orally disintegrating strip sildenafil for the treatment of erectile dysfunction: a prospective, randomized trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766267/
https://www.ncbi.nlm.nih.gov/pubmed/34710784
http://dx.doi.org/10.1016/j.esxm.2021.100453
work_keys_str_mv AT sangkumpremsant efficacyoftheorallydisintegratingstripsildenafilforthetreatmentoferectiledysfunctionaprospectiverandomizedtrial
AT sirisopanakun efficacyoftheorallydisintegratingstripsildenafilforthetreatmentoferectiledysfunctionaprospectiverandomizedtrial
AT matangwijittra efficacyoftheorallydisintegratingstripsildenafilforthetreatmentoferectiledysfunctionaprospectiverandomizedtrial
AT phengsalaeyada efficacyoftheorallydisintegratingstripsildenafilforthetreatmentoferectiledysfunctionaprospectiverandomizedtrial
AT lertsithichaipanuwat efficacyoftheorallydisintegratingstripsildenafilforthetreatmentoferectiledysfunctionaprospectiverandomizedtrial
AT ketsuwanchinnakhet efficacyoftheorallydisintegratingstripsildenafilforthetreatmentoferectiledysfunctionaprospectiverandomizedtrial
AT kochakarnwachira efficacyoftheorallydisintegratingstripsildenafilforthetreatmentoferectiledysfunctionaprospectiverandomizedtrial
AT kongchareonsombatwisoot efficacyoftheorallydisintegratingstripsildenafilforthetreatmentoferectiledysfunctionaprospectiverandomizedtrial